About: Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) scientific article published on 22 March 2019 (en)
publication date	wds:Q64063945-829A346E-C1F3-49E8-9ADA-37AEB1308327
publication date	2019-03-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64063945-79974CDD-897C-46AA-A3D8-47DB03A48A4B
language of work or name	English
cites work	wds:Q64063945-019C078B-2E9F-4DA5-AF43-1A11D16A3172 wds:Q64063945-03400A78-F1C9-491F-A076-EC20A76F6739 wds:Q64063945-1747557D-5502-4118-8479-F63F709864E0 wds:Q64063945-4EFD11BF-3402-4F33-A412-BAE822614554 wds:Q64063945-687D09F4-130B-4E7A-988E-0D98AB98D2E8 wds:Q64063945-68988609-AACD-4233-9D0B-B1FDE8C9AC20 wds:Q64063945-6A8043A6-7109-421C-9F6B-1029678605C0 wds:Q64063945-6B3DDECA-3758-406C-A725-3A18A34B268D wds:Q64063945-71B056A5-510E-4596-95E0-39FED4A171E9 wds:Q64063945-7E33C2AB-DA7B-415B-B131-A7B94EE4AAC5 wds:Q64063945-7ED60D9C-A47F-4DED-96AB-74D3F0D51C02 wds:Q64063945-82BE3E6C-EB86-492E-B44F-F182403B8862 wds:Q64063945-96F8BD26-3BC2-4096-BCE9-5DA2D880C4A1 wds:Q64063945-98402776-0D34-483C-B8B6-0EB71D1B1FC8 wds:Q64063945-9893916E-1607-4651-85A5-CD06057BA305 wds:Q64063945-9B080798-F71A-4102-8565-F6AA07F89C9B wds:Q64063945-9E878721-DBD5-4C08-BD35-CB1A14C82AF6 wds:Q64063945-A31701C6-8D54-4156-A76E-690DF2EAED5A wds:Q64063945-AB8145EE-0270-448D-9F68-F3E37848E508 wds:Q64063945-BC5F17AC-ABAD-4F52-BB9C-367EEEEC073F wds:Q64063945-BCEACA84-74AA-4492-8EC0-42EEBB664FB1 wds:Q64063945-C5187001-FA56-496D-9816-3F400ABD6090 wds:Q64063945-DC876AB4-3DC3-4FD0-A2C1-023DDC6D1B1B wds:Q64063945-E506F798-3724-498B-8145-C05081B1D047 wds:Q64063945-EBD5A1D4-0999-4185-B162-88E36AA29961 wds:Q64063945-EDC35720-B7C8-41FE-B203-F6DBE7D22A35 wds:Q64063945-F30DD1D6-F76A-4232-BE69-993CED7CEC5F wds:Q64063945-F4DE999D-6301-4E69-A944-BB2018C3569C wds:Q64063945-F9A7AF91-0B18-4B5E-9BBB-CF9AD5BCC349
cites work	Cellular immune correlates of protection against symptomatic pandemic influenza. Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review An avian cell line designed for production of highly attenuated viruses Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Recombinant MVA vaccines: dispelling the myths Efficacy of high-dose versus standard-dose influenza vaccine in older adults Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial Immunosenescence: Influenza vaccination and the elderly Homology between avian oncornavirus RNAs and DNA from several avian species Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. Economic burden of seasonal influenza in the United States Vaccines for preventing influenza in the elderly. Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults. Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine. Novel Platforms for the Development of a Universal Influenza Vaccine. Influenza vaccine supply, 2005-2006: did we come up short?
author name string	wds:Q64063945-2EACDE15-B72A-440F-A8FA-E84835C6B822 wds:Q64063945-3BA27DF0-D64B-4E32-A55D-ADDA9FDA0F17 wds:Q64063945-9071A7BF-B658-429C-A283-03BACD72C1D2 wds:Q64063945-9289551F-B4EC-4CC0-95B4-A773519E5947 wds:Q64063945-A8176D7B-E267-4393-8703-F2EF9CA446D2 wds:Q64063945-C7A21D97-42D0-41D9-AF81-DE417FD64196
author name string	Rachel Roberts Chris Ellis Thomas G Evans Megan Baker Catherine Mair Raquel L Ramon
rdfs:label	Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (en) Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (nl)
skos:prefLabel	Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (en) Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (nl)
name	Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (en) Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line (nl)
author	wds:Q64063945-1F0F6B76-B504-4584-95B6-9198EAC85AD0 wds:Q64063945-44A3F54F-73AF-4533-8EEC-911D0E91003B wds:Q64063945-5ABA7DF2-C748-47B2-A1D2-E44425A725C3 wds:Q64063945-5EAB8419-910F-467A-94D2-1539358E78BD wds:Q64063945-696AB221-5EEE-4264-B442-5B44E5FB2883 wds:Q64063945-97AE43A8-DA30-4CCD-9420-86CAFD03AAF2 wds:Q64063945-9AC62BB2-0184-4304-A2CE-28F47A8F6869 wds:Q64063945-ADFC7505-4AC3-4CDE-88DE-4F8D84981E10 wds:Q64063945-BDDB2EEA-83D7-42B9-A3CA-4E495F03F70F wds:Q64063945-D090BF69-EE26-426F-BE21-EB10496C8148 wds:Q64063945-E797ABE1-9328-424D-B1F0-DCF55ED15F0E
author	Sarah Gilbert Katie J. Ewer Adrian V. S. Hill

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software